ALBEMARLE CORP 8-K

What Happened
Albemarle Corporation announced on March 2, 2026 that it closed the previously announced sale of its 51% ownership interest in Ketjen Corporation to ChemCat AcquisitionCo, LLC (affiliated with KPS Capital Partners). Albemarle expects to receive approximately $547 million in cash (including $22 million of cash that was in Ketjen at closing). The company will keep a 49% minority stake in Ketjen and will retain 100% ownership of Ketjen’s Performance Catalyst Solutions business, which has been integrated into Albemarle’s product portfolio. Separately, Albemarle issued a press release announcing the redemption of its 4.650% Senior Notes due 2027 and launched offers to purchase up to $500 million aggregate principal of several other notes (see details below).

Key Details

• Sale closed March 2, 2026; Albemarle expects approx. $547 million cash proceeds (includes $22M cash in Ketjen).
• Combined pre‑tax proceeds from this sale and the January 2026 sale of Albemarle’s 50% interest in the Eurecat JV total about $670 million.
• Post‑close ownership: Albemarle retains 49% of Ketjen and 100% of Ketjen’s Performance Catalyst Solutions business.
• Debt actions announced (Offer to Purchase dated March 2, 2026): redemption of 4.650% Senior Notes due 2027 and offers to buy up to $500M of: 5.65% notes due 2052; 5.45% notes due 2044; Albemarle Wodgina 3.45% notes due 2029; and 5.05% notes due 2032.

Why It Matters
This transaction reduces Albemarle’s ownership in Ketjen while keeping exposure via a 49% stake and preserving the Performance Catalyst Solutions business within Albemarle’s product lines. The cash proceeds (and combined proceeds with the Eurecat sale) provide liquidity that the company says it expects to use to fund the announced tender offers and note redemption, which may affect Albemarle’s debt profile and interest costs. Investors should note the timing (closed March 2, 2026) and the company’s furnished press releases; the filing also includes customary forward‑looking statements about use of proceeds and completion of the tender offers.